Status:
UNKNOWN
Feasibility of Remote Evaluation and Monitoring of Acoustic Pathophysiological Signals With External Sensor Technology
Lead Sponsor:
Senti Tech Ltd
Conditions:
Respiratory Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of this study is to explore the acceptability and feasibility of a novel medical device system for remote monitoring of breath and heart sounds (replicating remotely, and in an easy-to-use gar...
Detailed Description
TITLE: Remote Evaluation and Monitoring of Acoustic Pathophysiological parameters with external sensor technology. DESIGN: First-In-Man and Feasibility study of the Senti Version 1 Device. AIMS: To ...
Eligibility Criteria
Inclusion
- Patients attending A\&E who are being discharged from A\&E into the care of the community respiratory team.
Exclusion
- Patients unable to give their consent.
- Patients with a known sensitivity or allergy to any of the components of the device.
- Patients with any active implanted devices (such as pacemakers or vagal nerve stimulators).
- Patients with existing pressure sores across the area this device would come into contact (predominantly, across the thorax).
- Patients with significant cognitive impairment or limiting physical disabilities - to the extent that they are not able to manage their own ADLs; except where sufficient family or care support is available to manage the device functions (in which case, the device may be used with caution).
Key Trial Info
Start Date :
February 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2021
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04693091
Start Date
February 1 2021
End Date
April 1 2021
Last Update
January 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Senti Tech
Liverpool, Merseyside, United Kingdom, L1 0AX